Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study

BACKGROUND: There are limited studies on treatment and survival analysis among patients with unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC) in routine practice in China. To address this gap, we conducted a prospective observational study in a cohort of patients treated at 11 hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuankai, Zhang, Xin, Wu, Gang, Xu, Jianping, He, Yong, Wang, Dong, Huang, Cheng, Chen, Mingwei, Yu, Ping, Yu, Yan, Li, Wei, Li, Qi, Hu, Xiaohua, Xia, Jinjing, Bu, Lilian, Yin, Angela, Zhou, Yigong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019386/
https://www.ncbi.nlm.nih.gov/pubmed/35465042
http://dx.doi.org/10.1016/j.lanwpc.2022.100452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019386/
https://www.ncbi.nlm.nih.gov/pubmed/35465042
http://dx.doi.org/10.1016/j.lanwpc.2022.100452

Ejemplares similares